Literature DB >> 20563896

Non-Hodgkin lymphomas of the oral cavity in AIDS patients in a reference hospital of infectious diseases in Argentina: report of eleven cases and review of the literature.

Marcelo Corti1, Maria Florencia Villafañe, Ruben Solari, Luis De Carolis, Diana Cangelosi, Jose Santoro, Ricardo Schtirbu, Daniel Lewi, Alicia Bistmans, Marina Narbaitz, Patricia Baré.   

Abstract

INTRODUCTION: Extranodal non-Hodgkin lymphoma (NHL) were commonly described in AIDS patients and are related with an atypical morphology and aggressive clinical course.
MATERIALS AND METHODS: In this single institutional study we evaluated the epidemiological, clinical, immunological, virological, histopathological and the outcome of eleven HIV/AIDS patients with oral cavity lymphomas (OCL).
RESULTS: Nine were males and seven intravenous drug abusers. The median of age was 33 years and the median of CD4 T cell counts at the time of diagnosis was 97 cell/µL. The majority of tumors presented as large and ulcerated masses involving the gingiva, the palate and the jaw. Six of these tumors were diffuse large B-cell lymphomas (DLBCL); three were Burkitt's lymphomas and the final case was a plasmablastic lymphoma. An association with Epstein-Barr virus (EBV) was found in three of the ten tested cases by in situ hybridization (EBER 1 and 2 probes) and immunohistochemistry (LMP-1). Human herpes virus-8 (HHV-8) was detected by polymerase chain reaction (PCR) in only one neoplasm. Six patients died without specific treatment; four received chemotherapy and highly active antiretroviral therapy (HAART) and three of them presented a prolonged survival. DISCUSSION: Combination of HAART and chemotherapy should modify the poor prognosis of AIDS patients with OCL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20563896     DOI: 10.1007/s12029-010-9173-9

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  16 in total

Review 1.  Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy.

Authors:  U Tirelli; M Spina; G Gaidano; E Vaccher; S Franceschi; A Carbone
Journal:  AIDS       Date:  2000-08-18       Impact factor: 4.177

Review 2.  Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations.

Authors:  C M Flaitz; C M Nichols; D M Walling; M J Hicks
Journal:  Oral Oncol       Date:  2002-01       Impact factor: 5.337

Review 3.  Extranodal non-Hodgkin's lymphomas of the oral cavity.

Authors:  R C Jordan; P M Speight
Journal:  Curr Top Pathol       Date:  1996

4.  Oral plasmablastic lymphoma in previously undiagnosed HIV disease.

Authors:  S R Porter; P Diz Dios; N Kumar; C Stock; A W Barrett; C Scully
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1999-06

5.  [Cavum lymphoma in a hemophilic patient with AIDS].

Authors:  M Corti; M F Villafañe; M Cermelj; M Candela; R Pérez Blanco; M Tezanos Pinto
Journal:  Medicina (B Aires)       Date:  2000       Impact factor: 0.653

6.  Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy.

Authors:  Sunita D Nasta; George M Carrum; Imran Shahab; Nicola A Hanania; Mark M Udden
Journal:  Leuk Lymphoma       Date:  2002-02

7.  Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection.

Authors:  H J Delecluse; I Anagnostopoulos; F Dallenbach; M Hummel; T Marafioti; U Schneider; D Huhn; A Schmidt-Westhausen; P A Reichart; U Gross; H Stein
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

8.  Absence of immunohistochemical evidence for human herpesvirus 8 (HHV8) in oral cavity plasmablastic lymphoma in an HIV-positive man.

Authors:  R S Brown; D A Power; H F Spittle; K J Lankester
Journal:  Clin Oncol (R Coll Radiol)       Date:  2000       Impact factor: 4.126

9.  Oral cavity lymphoma as secondary AIDS-defining neoplasm in a patient on HAART with immune reconstitution.

Authors:  Marcelo Corti; Rubén Solari; Diana Cangelosi; Luis De Carolis; Ricardo Schtirbu; Daniel Lewi
Journal:  Rev Soc Bras Med Trop       Date:  2007 Sep-Oct       Impact factor: 1.581

10.  Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8.

Authors:  Adina M Cioc; Carl Allen; John R Kalmar; Saul Suster; Robert Baiocchi; Gerard J Nuovo
Journal:  Am J Surg Pathol       Date:  2004-01       Impact factor: 6.394

View more
  5 in total

1.  Head and neck diffuse large B cell lymphomas (HN-DLBCL) in human immunodeficiency virus (HIV) positive patients: long-term results in the highly active antiretroviral therapy (HAART) era.

Authors:  Francesca De Felice; Andrea Di Mino; Lavinia Grapulin; Maria Lusia Mistrulli; Daniela Musio; Vincenzo Tombolini
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-12       Impact factor: 2.503

2.  Primary extranodal non-hodgkin lymphoma of the head and neck in patients with acquired immunodeficiency syndrome: a clinicopathologic study of 24 patients in a single hospital of infectious diseases in Argentina.

Authors:  Marcelo Corti; María Villafañe; Alicia Bistmans; Marina Narbaitz; Leonardo Gilardi
Journal:  Int Arch Otorhinolaryngol       Date:  2014-04-09

Review 3.  Oral manifestations of lymphoma: a systematic review.

Authors:  Taísa Domingues Bernardes Silva; Camila Belo Tavares Ferreira; Gustavo Boehmer Leite; José Roberto de Menezes Pontes; Héliton S Antunes
Journal:  Ecancermedicalscience       Date:  2016-08-17

4.  HIV-related non-Hodgkin lymphomas affecting the oral cavity: a clinicopathologic study of 11 cases.

Authors:  D-C Uchôa; F-S Pontes; L-L Souza; G-S Santos; A-C Prado-Ribeiro; T-B Brandão; L-R Oliveira; C-C Gomes; A-R Santos-Silva; F-P Fonseca; O-P Almeida; H-A Pontes
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-03-01

5.  Intraoral HIV-associated Burkitt's lymphoma: a rare case report with special emphasis on differential diagnosis.

Authors:  Mamata Kamat; Uma Datar; Sampada Kanitkar; Sanjay Byakodi
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2019-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.